NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company focused on improving surgical care for neurological disorders, announced that it will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, Nevada, and is set to deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time in TRACK 6 - Raphael 3. The presentation will cover commercialization updates and anticipated milestones for the OneRF® platform, which is designed for treatment of the brain, pain, and advanced drug delivery.
In addition to the presentation, Mr. Rosa will hold one-on-one meetings with institutional investors. He also participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here. The conference provides a platform for micro-cap companies to present to a curated audience of investors, analysts, and industry professionals. NeuroOne's participation underscores its commitment to advancing its technology and engaging with the investment community.
The OneRF® platform is a key focus for the company, offering a minimally invasive ablation system for neurological conditions. NeuroOne markets four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by combining diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs.
Investors and interested parties can access the live webcast of the presentation via the conference website here. For more information on the conference or to schedule a meeting with management, contact the conference representative or email NMTC@mzgroup.us. NeuroOne's participation in the Planet MicroCap Conference highlights its ongoing efforts to bring innovative solutions to the neurological device market and to communicate its progress to stakeholders.
